Contact and Intraocular Lenses Market

Increasing prevalence of various ocular disorders to Boost Market Growth

The prevalence of various ocular disorders, such as myopia and hypermetropia, is growing at an alarming rate worldwide. These ocular disorders are associated with a significant rise in the risks for vision impairment due to conditions such as high myopia and other diseases. According to an article published in ‘Investigative ophthalmology & visual science’, myopia affected ~30% of the world’s population in 2020; this number is expected to rise to 50% by 2050.

According to the World Health Organization (WHO), the cases of myopia are highest in East Asia, where China, Japan, South Korea, and Singapore have a prevalence of approximately 50%. Moreover, by 2050, the prevalence of myopia is projected to be much higher in high per capita income regions of the Asia-Pacific, i.e., in the East and South-East Asia, and in high-income North America, southern Latin America, all of Europe, North Africa, the Middle East, and about 30% of Africa will be similar to that in Asia today.

Furthermore, according to WHO, the global financial burden with the annual global costs of productivity losses associated with vision impairment from uncorrected myopia and presbyopia is estimated to be USD 244 billion and USD 25.4 billion, respectively.

Contact lenses and intraocular lenses are now commonly used to correct myopia, hyperopia, astigmatism, and presbyopia. There are other eye conditions as well, such as keratoconus and aniseikonia, which are better corrected with contact lenses. Intraocular lenses are commonly used during cataract surgery to replace the natural lens of the eye. Therefore, the increasing prevalence of eye disorders is expected to drive the growth of the Contact and Intraocular Lenses Market during the forecast period.

Increased awareness of eye health and the importance of regular eye examinations significantly influences the Global Contact and Intraocular Lenses Market Industry. Educational campaigns by health organizations and optometrists emphasize the necessity of vision correction, leading to higher demand for corrective lenses. This trend is particularly evident in developing regions, where access to eye care services is improving. As individuals become more proactive about their eye health, the market is poised for growth. The anticipated compound annual growth rate of 7.22% from 2025 to 2035 reflects this rising consciousness and its impact on lens adoption rates.

The rise of e-commerce platforms has transformed the Global Contact and Intraocular Lenses Market Industry by providing consumers with convenient access to a wide range of products. Online retailers offer competitive pricing and the convenience of home delivery, appealing to tech-savvy consumers. This shift in purchasing behavior is particularly pronounced among younger demographics who prefer online shopping. As e-commerce continues to expand, it is likely to drive sales growth in the contact and intraocular lens segments. The ease of access to various brands and types of lenses online may further enhance market penetration and consumer engagement.

The Global Contact and Intraocular Lenses Market Industry experiences growth driven by the increasing prevalence of vision disorders such as myopia, hyperopia, and astigmatism. As populations age, the demand for corrective lenses rises, with millions affected globally. For instance, the World Health Organization indicates that uncorrected refractive errors affect approximately 2.7 billion people worldwide. This growing need for vision correction fuels the market, which is projected to reach 11 USD Billion in 2024. The demand for both contact lenses and intraocular lenses is likely to continue expanding as awareness of eye health increases.

Technological innovations play a pivotal role in shaping the Global Contact and Intraocular Lenses Market Industry. Advances in materials and manufacturing processes have led to the development of more comfortable, durable, and effective lenses. For example, the introduction of silicone hydrogel materials has enhanced oxygen permeability, improving wearability for contact lens users. Furthermore, the emergence of multifocal and toric lenses caters to diverse vision needs, thereby broadening the consumer base. These advancements are expected to contribute to the market's growth trajectory, potentially reaching 23.7 USD Billion by 2035, as consumers increasingly seek high-quality vision correction solutions.

Investment in eye care infrastructure is a crucial driver for the Global Contact and Intraocular Lenses Market Industry. Governments and private entities are increasingly funding eye care facilities and services, particularly in underserved regions. This investment not only improves access to eye care but also promotes the adoption of advanced lens technologies. Enhanced infrastructure facilitates better diagnosis and treatment options, leading to a higher demand for both contact and intraocular lenses. As eye care becomes more accessible, the market is expected to flourish, aligning with the projected growth trends in the coming years.

Major market players are spending a lot of money on R&D to increase their product lines, which will help the contact and intraocular lenses market grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, including new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the contact and intraocular lenses industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.

One of the primary business strategies adopted by manufacturers in the global contact and intraocular lenses industry to benefit clients and expand the contact and intraocular lenses market sector is to manufacture locally to reduce operating costs. In recent years, contact and intraocular lenses has provided some of the most significant benefits.

Johnson & Johnson Services, Inc. (US) manufactures medical devices for various specialties such as orthopedics, cardiovascular diseases, and many others. J&J Services has acquired and merged with various other companies to expand its portfolio of endoscopic devices, pharmaceuticals, and consumer health products. The company operates through its various subsidiary Janssen Pharmaceutica (Belgium), Neutrogena (US), DePuy Synthes Companies (US), Ethicon Inc. (US), Janssen-Cilag (US), Actelion (Switzerland), LifeScan, Inc. (US), Johnson & Johnson Vision Care, Inc. (US), and others.

In February 2021, Johnson & Johnson Vision, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies, announced that the U.S. Food and Drug Administration (FDA) approved the TECNIS Eyhance and TECNIS Eyhance Toric II intraocular lens (IOL) for the treatment of cataract patients in the US.